The authors used a diverse range of in vitro assays, including CRISPR/Cas9 gene editing, cell migration, cell adhesion and spreading assays, as well as western blot and flow cytometry analyses, utilizing MDA-MB-231 and 4T1 TNBC cell lines.
[Oncogene]